Results 211 to 220 of about 48,625 (267)

Biomimetic hybrid nanocarriers hitchhike neutrophils for targeted ginsenoside Rc delivery to BMSCs: ameliorating postmenopausal osteoporosis via iron homeostasis regulation. [PDF]

J Nanobiotechnology
He Y, Fang D, Huang B, Chen X, Zhang Z, Wang Z, Jiang Q, Guo B, Xiao W.   +8 more
europepmc   +1 more source

Sijing Pill modulates PGE2/EP4/PI3K-AKT pathway via gut-bone axis to treat postmenopausal osteoporosis. [PDF]

Front Microbiol
Zhu X, Li Y, Meng X, Jiang T, Li C, Zhu X, Yin Z, Guo J, Su X.   +8 more
europepmc   +1 more source

LUMIADE 3: Therapeutic Equivalence of Denosumab Biosimilar FKS518 to Reference Product in Postmenopausal Osteoporosis. [PDF]

J Endocr Soc
Krecipro-Nizinska E, Pluskiewicz W, Supronik J, Szeles P, Petit-Frere C, Varone E, Ferrari S, Valter I.   +7 more
europepmc   +1 more source

Designed bone-targeting ROS-responsive nanoplatform for precision glycolysis inhibition in postmenopausal osteoporosis. [PDF]

Bioact Mater
Wu Q, Miao J, Chen Y, Yang Y, Liang H, Yu C, Wang C, Tu Y, Wu Y, Xu Y, Yang X, Kwan KYH, Shi C, Wang X, Xu J, Jin H.   +15 more
europepmc   +1 more source

Cost-effectiveness analysis of Chinese patent medicines for the treatment of postmenopausal osteoporosis in China. [PDF]

Front Public Health
Wang C, Lin X, Liu J, Zhang Y, You R.
europepmc   +1 more source

Value of serum uric acid in a risk prediction model for postmenopausal osteoporosis. [PDF]

Arch Gynecol Obstet
Li B, Ye Y, Li J.
europepmc   +1 more source

Correction to: "Effective Brief, Low-impact, High-intensity Osteogenic Loading in Postmenopausal Osteoporosis".

J Clin Endocrinol Metab
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Postmenopausal Osteoporosis

New England Journal of Medicine, 2023
Marcella D Walker, Elizabeth Shane
exaly   +3 more sources

Treatment of Postmenopausal Osteoporosis

New England Journal of Medicine, 1998
Osteoporosis affects an estimated 75 million people in Europe, the United States, and Japan.1 It is a preventable and treatable condition, yet many people with osteoporosis remain unrecognized and untreated. The purpose of this review is to consider the evidence that treatments for postmenopausal osteoporosis are effective and safe.
Richard Eastell, Eastell Richard
exaly   +3 more sources

Postmenopausal Osteoporosis

Medical Clinics of North America, 1987
Osteoporosis is a major public health problem, particularly for the postmenopausal woman. With the withdrawal of estrogen at menopause, bone resorption begins to exceed formation in remodeling cycles and bone mass is inexorably lost. Clearly, preventing postmenopausal osteoporosis is the aim of management.
S J, Silverberg, R, Lindsay
openaire   +4 more sources